Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma
Kgokolo, Mahlatse C.M., Malinga, Nonkululeko Z., Steel, Helen C., Meyer, Pieter W.A., Smit, Teresa, Anderson, Ronald, Rapoport, Bernardo L.
Published in Translational oncology (01.04.2024)
Published in Translational oncology (01.04.2024)
Get full text
Journal Article
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma
Malinga, Nonkululeko Z., Siwele, Shalete C., Steel, Helen C., Kwofie, Luyanda L.I., Meyer, Pieter W.A., Smit, Teresa, Anderson, Ronald, Rapoport, Bernardo L., Kgokolo, Mahlatse C.M.
Published in Translational oncology (01.05.2022)
Published in Translational oncology (01.05.2022)
Get full text
Journal Article
Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients
Kgokolo, Mahlatse C M, Anderson, Katherine, Siwele, Shalate C, Steel, Helen C, Kwofie, Luyanda L I, Sathekge, Mike M, Meyer, Pieter W A, Rapoport, Bernardo L, Anderson, Ronald
Published in Frontiers in oncology (11.02.2022)
Published in Frontiers in oncology (11.02.2022)
Get full text
Journal Article